UDC

612.017.1:577.175.14

DOI

10.37482/2687-1491-Z139

Authors

Natal’ya P. Geshavets*/** ORCID: https://orcid.org/0000-0001-5822-7281
Kseniya O. Pashinskaya* ORCID: https://orcid.org/0000-0001-6774-4598
Liliya K. Dobrodeeva* ORCID: https://orcid.org/0000-0003-3211-7716

*N. Laverov Federal Center for Integrated Arctic Research of the Ural Branch of the Russian Academy of Sciences (Arkhangelsk, Russian Federation)
**Northern (Arctic) Federal University named after M.V. Lomonosov (Arkhangelsk, Russian Federation)

Corresponding author: Natal’ya Geshavets,
address: prosp. Lomonosova 249, Arkhangelsk, 163000, Russian Federation;
e-mail: geshavetsnp@mail.ru

Abstract

An increase in proinflammatory cytokine content in the blood is a stereotypical inflammatory response, regardless of the etiology or type of inflammation. Since cytokines exhibit pleiotropy, they serve as signalling molecules in intercellular interactions and stimulate the functional activity of cells, their proliferation and differentiation. The purpose of this study was to identify the frequency of elevated cytokine levels in dyslipoproteinemia in adults with different body weight living in the European North of Russia. Materials and methods. The study involved 313 residents of Arkhangelsk aged 45–60 years: with normal body weight (211 subjects; body mass index up to 30 kg/m2) and obesity (102 subjects; body mass index 31–40 kg/m2). The enzymatic and turbidimetric methods were applied to evaluate lipid profile parameters using an automatic biochemical analyser; cytokine levels were determined using solid-phase enzyme immunoassay. Results. In subjects with normal body weight, elevated blood concentrations of the cytokines under study coinciding with dyslipoproteinemia were detected in 2–11 % of cases. In obesity, elevated cytokine levels were 2–7 times more frequent; the sharpest differences were observed regarding IL-6, whose elevated concentrations reached 44 % of cases. A significant increase in IL-1ß concentrations in the blood of the subjects is associated with an increase in the levels of low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) as well as triglycerides (TG). The frequency of increased TNF-α levels was the most significant (36.28 %) at abnormally high TG concentrations. Elevated IL-6 levels were most often associated with an increase in the blood concentration of several transport forms: LDL, VLDL, oxidized LDL, and TG. In over 40 % of cases, increased IL-10 was observed in the blood of individuals with abnormally high levels of LDL and VLDL. Thus, obese residents of the European North of Russia are characterized by a more pronounced cytokine response. At the same time, cytokine response (irrespective of the body mass) is primarily associated with an increase in the blood levels of LDL, VLDL and oxidized LDL.

Keywords

cytokines, cytokine response, inflammation, lipid profile, dysliporoteinemia, obesity, European North of Russia

References

1. Le G., Novotny S.A., Mader T.L., Greising S.M., Chan S.S.K., Kyba M., Lowe D.A., Warren G.L. A Moderate Oestradiol Level Enhances Neutrophil Number and Activity in Muscle After Traumatic Injury but Strength Recovery Is Accelerated. J. Physiol., 2018, vol. 596, no. 19, pp. 4665–4680. DOI: 10.1113/JP276432
2. Knyazeva L.I., Shishova A.S., Stepchenko M.A. Dinamika pokazateley immunnogo statusa i rigidnosti sosudistoy stenki u bol’nykh arterial’noy gipertenziey s ozhireniem [Dynamics of Indicators of the Immune Status and Rigidity of the Vascular Wall in Patients Suffering from Arterial Hypertension with Obesity]. Fundamental’nye issledovaniya, 2012, no. 7-2, pp. 338–343.
3. Giannakopoulou C.E., Sotiriou A., Dettoraki M., Yang M., Perlikos F., Toumpanakis D., Prezerakos G., Koutsourelakis I., Kastis G.A., Vassilakopoulou V., Mizi E., Papalois A., Greer J.J., Vassilakopoulos T. Regulation of Breathing Pattern by IL-10. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2019, vol. 317, no. 1, pp. R190–R202. DOI: 10.1152/ajpregu.00065.2019
4. Steensberg A., Febbraio M.A., Osada T., Schjerling P., Hall G., Saltin B., Pedersen B.K. Interleukin-6 Production in Contracting Human Skeletal Muscle Is Influenced by Pre-Exercise Glycogen Content. J. Physiol., 2001, vol. 537, no. 2, pp. 633–639. DOI: 10.1111/j.1469-7793.2001.00633.x
5. Snodgrass R.G., Boß M., Zezina E., Weigert A., Dehne N., Fleming I., Brüne B., Namgaladze D. Hypoxia Potentiates Palmitate-Induced Pro-Inflammatory Activation of Primary Human Macrophages. J. Biol. Chem., 2016, vol. 291, no. 1, pp. 413–424. DOI: 10.1074/jbc.M115.686709
6. Katinas E.B. Ryabova M.A., Karpishchenko S.A. Tsitokinovyy sostav laringeal’nogo sekreta u bol’nykh retsidiviruyushchim papillomatozom gortani pri mestnoy terapii interferonom al’fa-2 [Cytokine Composition of Laryngeal Secretion in Patients with Recurrent Laryngeal Papillomatosis at Local Therapy with Interferon Alfa-2]. Rossiyskiy immunologicheskiy zhurnal, 2008, vol. 2, no. 2, pp. 186–196.
7. Van Snick J. Interleukin-6: An Overview. Annu. Rev. Immunol., 1990, vol. 8, pp. 253–278. DOI: 10.1146/annurev.iy.08.040190.001345
8. Schwartz E.A., Zhang W.-Y., Karnik S.K., Borwege S., Anand V.R., Laine P.S., Su Y., Reaven P.D. Nutrient Modification of the Innate Immune Response: A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation. Arterioscler. Thromb. Vasc. Biol., 2010, vol. 30, no. 4, pp. 802–808. DOI: 10.1161/ATVBAHA.109.201681
9. Titov V.N., Rozhkova T.A., Kaminnaya V.I. The Role of Excessive Meat Intake in the Pathogenesis of Atherosclerosis and Atheromatosis in Humans and Animals (Review). J. Med. Biol. Res., 2018, vol. 6, no. 2, pp. 174– 187. DOI: 10.17238/issn2542-1298.2018.6.2.174
10. Titov V.N., Krylin V.V., Shiryaeva Yu.K. Profilaktika ateroskleroza. Izbytok v pishche pal’mitinovoy kisloty – prichina giperkholesterinemii, sindroma vospaleniya, rezistentnosti miotsitov k insulinu i apoptoza [Prevention of Atherosclerosis. Excess Palmitic Acid in Food Is a Cause of Hypercholesterolemia, Inflammatory Syndrome, Insulin Resistance in Myocytes, and Apoptosis]. Klinicheskaya laboratornaya diagnostika, 2011, no. 2, pp. 4–15.
11. Cury-Boaventura M.F., Gorjão R., Martins de Lima T., Fiamoncini J., Godoy A.B.P., Deschamphs F.C., Soriano F.G., Curi R. Effect of Medium/ω-6 Long Chain Triglyceride-Based Emulsion on Leucocyte Death and Inflammatory Gene Expression. Clin. Exp. Immunol., 2011, vol. 165, no. 3, pp. 383–392. DOI: 10.1111/j.1365-2249.2011.04432.x
12. Stavinskaya O.A., Balashova S.N. Uchastie leptina v regulyatsii programmiruemoy kletochnoy gibeli u lits s dislipidemiey [The Involvement of Leptin in the Regulation of Programmed Cell Death in Persons with Dyslipidemia]. Ekologiya cheloveka, 2015, no. 12, pp. 34–37.
13. Diaconu A., Coculescu B.I., Manole G., Vultur H., Coculescu E.C., Stocheci C.M., Tudorache I.S., Dincă A.L., Dincă V.G. Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) – Possible Diagnostic and Risk Biomarker in Chronic Ischaemic Heart Disease. J. Enzyme Inhib. Med. Chem., 2021, vol. 36, no. 1, pp. 68–73. DOI: 10.1080/14756366.2020.1839447
14. Nezos A., Skarlis C., Psarrou A., Markakis K., Garantziotis P., Papanikolaou A., Gravani F., Voulgarelis M., Tzioufas A.G., Koutsilieris M., Moutsopoulos H.M., Kotsifaki E., Mavragani C.P. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma? Front. Immunol., 2021, vol. 12. Art. no. 683623. DOI: 10.3389/fimmu.2021.683623
15. Yazdi A.S., Ghoreschi K. The Interleukin-1 Family. Adv. Exp. Med. Biol., 2016, vol. 941, pp. 21–29. DOI: 10.1007/978-94-024-0921-5_2
16. Shin M.S., Kang Y., Lee N., Wahl E.R., Kim S.H., Kang K.S., Lazova R., Kang I. Self Double-Stranded (ds) DNA Induces IL-1β Production from Human Monocytes by Activating NLRP3 Inflammasome in the Presence of AntidsDNA Antibodies. J. Immunol., 2013, vol. 190, no. 4, pp. 1407–1415. DOI: 10.4049/jimmunol.1201195
17. Snodgrass R.G., Huang S., Namgaladze D., Jandali O., Shao T., Sama S., Brüne B., Hwang D.H. Docosahexaenoic Acid and Palmitic Acid Reciprocally Modulate Monocyte Activation in Part Through Endoplasmic Reticulum Stress. J. Nutr. Biochem., 2016, vol. 32, pp. 39–45. DOI: 10.1016/j.jnutbio.2016.01.010
18. Danilova G.A. Mekhanizmy deystviya interleykina-1β na tsentral’nuyu khemoretseptsiyu [Mechanisms of Interleukin-1β Action on Central Chemoreception]. XXII s”ezd Fiziologicheskogo obshchestva im. I.P. Pavlova [The 22nd Congress of I.P. Pavlov Physiological Society]. Volgograd, 2013, pp. 142–143.
19. Liu J., Cao L., Feng Y., Li Y., Li T. MiR-338-3p Inhibits TNF-α-Induced Lipogenesis in Human Sebocytes. Biotechnol. Lett., 2017, vol. 39, no. 9, pp. 1343–1349. DOI: 10.1007/s10529-017-2369-3
20. Montier Y., Lorentz A., Krämer S., Sellge G., Schock M., Bauer M., Schuppan D., Bischoff S.C. Central Role of IL-6 and MMP-1 for Cross Talk Between Human Intestinal Mast Cells and Human Intestinal Fibroblasts. Immunobiology, 2012, vol. 217, no. 9, pp. 912–919. DOI: 10.1016/j.imbio.2012.01.003
21. Ridker P.M., MacFadyen J.G., Glynn R.J., Bradwin G., Hasan A.A., Rifai N. Comparison of Interleukin-6, C-Reactive Protein, and Low-Density Lipoprotein Cholesterol as Biomarkers of Residual Risk in Contemporary Practice: Secondary Analyses from the Cardiovascular Inflammation Reduction Trial. Eur. Heart J., 2020, vol. 41, no. 31, pp. 2952–2961. DOI: 10.1093/eurheartj/ehaa160
22. Señarís R.M., Trujillo M.L., Navia B., Comes G., Ferrer B., Giralt M., Hidalgo J. Interleukin-6 Regulates the Expression of Hypothalamic Neuropeptides Involved in Body Weight in a Gender-Dependent Way. J. Neuroendocrinol., 2011, vol. 23, no. 8, pp. 675–686. DOI: 10.1111/j.1365-2826.2011.02158.x
23. Samodova A.V., Dobrodeeva L.K., Shtaborov V.A., Pashinskaya K.O. Vliyanie reaktsiy mozgovogo natriyureticheskogo peptida, irisina, endotelina 1 na sostoyanie immunnoy sistemy, rabotayushchikh na arkhipelage Shpitsbergen, v zavisimosti ot sroka prozhivaniya [Influence of Brain Natriuretic Peptide, Irisin and Endothelin-1 Reactions on the Immune System in Persons Working in the Svalbard Archipelago Depending on Duration of Stay]. Vestnik Kol’skogo nauchogo tsentra RAN, 2018, vol. 10, no. 3, pp. 87–92.
24. Wedell-Neergaard A.S., Lang Lehrskov L., Christensen R.H., Legaard G.E., Dorph E., Larsen M.K., Launbo N., Fagerlind S.R., Seide S.K., Nymand S., Ball M., Vinum N., Dahl C.N., Henneberg M., Ried-Larsen M., Nybing J.D., Christensen R., Rosenmeier J.B., Karstoft K., Pedersen B.K., Ellingsgaard H., Krogh-Madsen R. Exercise-Induced Changes in Visceral Adipose Tissue Mass Are Regulated by IL-6 Signaling: A Randomized Controlled Trial. Cell Metab., 2019, vol. 29, no. 4, pp. 844–855. DOI: 10.1016/j.cmet.2018.12.007
25. Wang X., Wong K., Ouyang W., Rutz S. Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. Cold Spring Harb. Perspect. Biol., 2019, vol. 11, no. 2. Art. no. a028548. DOI: 10.1101/cshperspect.a028548
26. Dhus O., Bunk S., von Aulock S., Hermann C. IL-10 Release Requires Stronger Toll-Like Receptor 4-Triggering Than TNF: A Possible Explanation for the Selective Effects of Heterozygous TLR4 Polymorphism Asp(299)Gly on IL-10 Release. Immunobiology, 2008, vol. 213, no. 8, pp. 621–627. DOI: 10.1016/j.imbio.2008.03.001